Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Naltriben: potential new pharmacotherapeutic for reducing alcohol intake

Jan. 17, 2000

Pharmacological profile of SR-141716A, a selective CB1 antagonist, further characterized

Dec. 29, 1999

Brain cocaine receptor ligands from RTI with favorable properties for pharmaceutical, imaging use

Dec. 28, 1999

New agent for treating cocaine dependency in development at RBI

Dec. 22, 1999

Preclinical studies validate Nabi's novel approach to treating and preventing nicotine addiction

Dec. 20, 1999

Novartis reports setbacks and advances in the development of new chelating agents

Dec. 8, 1999

Glaxo Wellcome's Zyban approved in The Netherlands for smoking cessation

Dec. 3, 1999

Neuronal nicotinic acetylcholine receptor ligands in early development at Pfizer

Nov. 30, 1999

Pfizer discloses modulators of cholinergic function for smoking cessation, etc.

Nov. 29, 1999

Development of potential new antiaddictive agent supported by NIDA

Oct. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...